Reevaluating cathepsin D as a biomarker for breast cancer: Serum activity levels versus histopathology
Daniel E. Abbott, Naira V. Margaryan, Jacqueline S. Jeruss, Seema Ahsan Khan, Virginia Kaklamani, David J. Winchester, Nora M Hansen, Alfred W Rademaker, Zhila Khalkhali-Ellis, Mary J.C. Hendrix
Dive into the research topics of 'Reevaluating cathepsin D as a biomarker for breast cancer: Serum activity levels versus histopathology'. Together they form a unique fingerprint.